What is Prima?
Prima, legally known as The Uplifters Prima, PBC, operates as a Public Benefit Corporation dedicated to addressing modern stress and wellness challenges. The company formulates and offers high-quality skincare, body care, supplements, and wellness products that blend therapeutic CBD with functional botanicals. Emphasizing clean, clinically formulated, and transparently sourced ingredients, Prima is committed to sustainable practices, rigorous testing, and ethical supply chain accountability. Its operations are further validated by B Corp and climate and plastic neutral certifications. While rooted in Santa Monica, California, the company is based in Austin, Texas, and distributes its products direct-to-consumer online and through select retail partners.
How much funding has Prima raised?
Prima has raised a total of $9.2M across 1 funding round:
Angel/Seed
$9.2M
Angel/Seed (2021): $9.2M with participation from Greycroft Partners, H Ventures, Defy, and Lerer Hippeau Ventures
Key Investors in Prima
Greycroft Partners
Greycroft Partners is a venture capital firm specializing in investments within the internet and mobile markets, known for leveraging its extensive network to support entrepreneurial growth and market entry.
Defy
Defy, a long-standing manufacturer of durable home appliances, is part of the Arçelik group and brings a unique industrial and consumer goods perspective to its investment portfolio.
Lerer Hippeau Ventures
Lerer Hippeau Ventures is an early-stage venture capital firm that supports innovative startups, particularly in the Seed and Pre-Seed rounds, with a focus on fostering long-term success through operational expertise.
What's next for Prima?
The recent major strategic investment signals a pivotal growth phase for Prima, likely enabling the company to scale its operations, expand its product development pipeline, and enhance its market reach. As a Public Benefit Corporation, Prima is poised to leverage this capital to further its mission of promoting holistic well-being while maintaining its commitment to sustainability and ethical business practices. The company's trajectory suggests a focus on deepening its scientific validation and potentially exploring new therapeutic applications for its botanical formulations.
See full Prima company page
